[go: up one dir, main page]

KR19990008319A - 섬유아세포 성장 인자 15 - Google Patents

섬유아세포 성장 인자 15 Download PDF

Info

Publication number
KR19990008319A
KR19990008319A KR1019970707845A KR19970707845A KR19990008319A KR 19990008319 A KR19990008319 A KR 19990008319A KR 1019970707845 A KR1019970707845 A KR 1019970707845A KR 19970707845 A KR19970707845 A KR 19970707845A KR 19990008319 A KR19990008319 A KR 19990008319A
Authority
KR
South Korea
Prior art keywords
polypeptide
polynucleotide
cell
dna
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019970707845A
Other languages
English (en)
Korean (ko)
Inventor
그린존엠
로젠크레이그에이
Original Assignee
벤슨로버트에이치
휴먼게놈사이언시즈,인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 벤슨로버트에이치, 휴먼게놈사이언시즈,인코포레이티드 filed Critical 벤슨로버트에이치
Publication of KR19990008319A publication Critical patent/KR19990008319A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
KR1019970707845A 1995-06-05 1995-06-05 섬유아세포 성장 인자 15 Withdrawn KR19990008319A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007156 WO1996039509A1 (fr) 1995-06-05 1995-06-05 Facteur 15 de croissance des fibroblastes

Publications (1)

Publication Number Publication Date
KR19990008319A true KR19990008319A (ko) 1999-01-25

Family

ID=22249254

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970707845A Withdrawn KR19990008319A (ko) 1995-06-05 1995-06-05 섬유아세포 성장 인자 15

Country Status (5)

Country Link
EP (1) EP0832216A4 (fr)
JP (1) JPH11506919A (fr)
KR (1) KR19990008319A (fr)
CA (1) CA2217301A1 (fr)
WO (1) WO1996039509A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876967A (en) * 1995-05-12 1999-03-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-2 and methods of use
US5693775A (en) * 1995-05-12 1997-12-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
US6403557B1 (en) 1996-11-27 2002-06-11 Human Genome Sciences, Inc. Fibroblast growth factor-13
US5728546A (en) 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
EP0935654A4 (fr) * 1996-03-21 2000-07-05 Univ Johns Hopkins Med Facteur 3 homologue du facteur de croissance des fibroblastes (fhf-3) et procedes d'utilisation
US6020189A (en) * 1996-08-30 2000-02-01 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factors (FHFs) and methods of use
WO2000060085A1 (fr) * 1999-04-02 2000-10-12 Millennium Pharmaceuticals, Inc. Facteur de croissance 20 des fibroblastes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956455A (en) * 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
EP0246753B1 (fr) * 1986-04-22 1994-07-13 The Salk Institute For Biological Studies Antagonistes du facteur de croissance des fibroblastes
EP0608546A3 (en) * 1992-12-22 1995-09-27 Takeda Chemical Industries Ltd Glia activating factor (gaf), antibodies against it and their uses.
US5817485A (en) * 1994-03-08 1998-10-06 Human Genome Sciences, Inc. Nucleic acids and cells for recombinant production of fibroblast growth factor-10
US5693775A (en) * 1995-05-12 1997-12-02 The Johns Hopkins University School Of Medicine Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
US5773252A (en) * 1995-06-05 1998-06-30 Human Genome Sciences, Inc. Fibroblast growth factor 15

Also Published As

Publication number Publication date
WO1996039509A1 (fr) 1996-12-12
JPH11506919A (ja) 1999-06-22
AU711647B2 (en) 1999-10-21
EP0832216A4 (fr) 1999-06-16
AU2767495A (en) 1996-12-24
CA2217301A1 (fr) 1996-12-12
EP0832216A1 (fr) 1998-04-01

Similar Documents

Publication Publication Date Title
US5773252A (en) Fibroblast growth factor 15
US20100041136A1 (en) Connective Tissue Growth Factor-2
EP0815115B1 (fr) Facteur-2 de croissance des keratinocytes
US5858705A (en) Polynucleotides encoding human DNA ligase III and methods of using these polynucleotides
US7045301B2 (en) Endothelial-monocyte activating polypeptide III antibodies
AU702131B2 (en) Fibroblast growth factor-14
US5763214A (en) Fibroblast growth factor 11
US6368822B1 (en) Fibroblast growth factor 13
AU702682B2 (en) Fibroblast growth factor 13
KR19990008319A (ko) 섬유아세포 성장 인자 15
US20030022312A1 (en) Human hepatoma-derived growth factor-2
KR19990007806A (ko) 전환 성장 인자 α ＨＩＩ
US7338934B2 (en) Fibroblast growth factor-14
AU711647C (en) Fibroblast growth factor 15
AU748429B2 (en) Fibroblast growth factor 11
AU752592B2 (en) Fibroblast growth factor 15
KR19980703870A (ko) 섬유아세포 성장 인자-11
MXPA97009217A (en) Growth factor 13 of fibroblas
MXPA97007897A (en) Factor-11 fibroblas growth
KR19980703677A (ko) 섬유아세포 성장 인자-14
MXPA97006854A (en) Factor 14 of fibroblas growth
MXPA97008493A (en) Factor 15 of fibroblas growth
CA2220988A1 (fr) Facteur de croissance des fibroblastes 13
JP2003047468A (ja) 線維芽細胞増殖因子１４

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19971105

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid